Piper Jaffray to Co-Host China Life Sciences Event in Shanghai
03 November 2006 - 5:08AM
PR Newswire (US)
SHANGHAI, China, Nov. 2 /PRNewswire-FirstCall/ -- Piper Jaffray
will host its first China Life Sciences Event on Wednesday, Nov. 15
in Shanghai. The event is co-hosted by O'Melveny & Myers LLP
and Deloitte Touche. The China Life Sciences Event, which showcases
some of the most innovative companies in the life sciences sector,
will provide investors and corporate executives a unique venue in
which to hear first-hand about prospects, opportunities, risks and
challenges in this growing health-related market segment. The
conference agenda includes presentation topics covering the growth
of life sciences companies, attractive opportunities for
institutional investors, pertinent considerations for companies in
this sector and the changing life sciences climate in China.
Keynote addresses will be presented by Gerald Chan, chairman of the
Morningside Group and Ren Dequan, former deputy commissioner of the
State Food and Drug Administration (SFDA). Other presentations will
highlight perspectives from venture and private equity investors,
an analysis of the U.S. capital markets and updates from
biopharmaceutical and medical device company executives. Additional
topics will include: intellectual property protection and
enforcement, the regulatory approval process, strategic alliances
and strategies for mergers and acquisitions. Companies scheduled to
participate in the China Life Sciences Event include: Aura
Partners, BioVeda Capital, Bridge Pharmaceuticals, Capital BioChip,
China Medipharm, China Medical, ChongQing JingShan, Curis, Eli
Lily, Fidelity Ventures, Green Valley, Hutchinson MediPharma
Limited, IDG Technology Venture Investment, Lifetech Scientific,
Medsphere, Microport Medical Co., Ltd., Morningside Group, Otsuka
China, Pfizer, Profex, SAIF Partners, SIG Capital Limited, Simcere
Pharmaceuticals, Sinocro Partners Limited, Summit Life Sciences,
Sunway Biotech Co., Ltd., TongJiTang and WI Harper Group. Company
and investor participation in the China Life Sciences Event is by
invitation only. Piper Jaffray clients interested in attending
should contact their Piper Jaffray representative. About Piper
Jaffray Piper Jaffray Companies is a leading, international middle
market investment bank and institutional securities firm, serving
the needs of middle market corporations, private equity groups,
public entities, nonprofit clients and institutional investors.
Founded in 1895, Piper Jaffray provides a comprehensive set of
products and services, including equity and debt capital markets
products; public finance services; mergers and acquisitions
advisory services; high-yield and structured products;
institutional equity and fixed-income sales and trading; and equity
and high-yield research. With headquarters in Minneapolis, Piper
Jaffray has 25 offices across the United States and international
locations in London, Madrid and Shanghai. The firm's UK operating
subsidiary, Piper Jaffray Ltd., is authorized and regulated by the
Financial Services Authority and is a member of the London Stock
Exchange. Piper Jaffray & Co. is the firm's principal operating
subsidiary. (NYSE:PJC) ( http://www.piperjaffray.com/ ) Since 1895.
Member SIPC and NYSE. DATASOURCE: Piper Jaffray CONTACT: Susan
Beatty, Media Relations, of Piper Jaffray, +1-612-303-5680 Web
site: http://www.piperjaffray.com/
Copyright
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Aug 2023 to Aug 2024